Revenue: The sum of all revenue fields included for a company's operating activities.
Protagonist Therapeutics, Inc. (PTGX) had Revenue of $46.02M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
|
Revenue |
$46.02M |
$-130.15M |
|
-- |
|
$46.02M |
|
$204.14M |
|
$-158.13M |
|
$28.82M |
|
$-129.31M |
|
$-129.31M |
|
$-130.15M |
|
$-130.15M |
|
$-130.15M |
|
$-130.15M |
|
$-158.13M |
|
$-162.48M |
|
63.57M |
|
63.57M |
|
$-2.05 |
|
$-2.05 |
|
| Balance Sheet Financials | |
$577.57M |
|
$3.86M |
|
$90.61M |
|
$668.19M |
|
$45.44M |
|
-- |
|
$8.04M |
|
$53.48M |
|
$614.71M |
|
$614.71M |
|
$614.71M |
|
62.58M |
|
| Cash Flow Statement Financials | |
$57.67M |
|
$-49.33M |
|
$22.86M |
|
$97.47M |
|
$128.68M |
|
$31.20M |
|
$45.97M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.71 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-343.63% |
|
-343.63% |
|
-353.10% |
|
-281.01% |
|
-282.83% |
|
$56.08M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
-- |
|
380.30 |
|
0.96 |
|
-21.17% |
|
-21.17% |
|
-19.48% |
|
-21.17% |
|
$9.82 |
|
$0.88 |
|
$0.91 |
|